Two scientists behind suit to block stem-cell research funding speak with lawmakers

NewsGuard 100/100 Score
The Wall Street Journal: "The two scientists behind the lawsuit that has temporarily blocked federal funding for embryonic stem-cell research said Wednesday they were motivated by ethical objections to destroying human embryos for medical research. The scientists, James Sherley of Boston and Theresa Deisher of Seattle, had never met until this week, when they flew to Washington to confer with House and Senate aides and lobby against research using embryonic stem cells. They were recruited separately by lawyers looking to challenge the federal policy. … A federal judge last week ruled the research violated federal law. The decision rocked the scientific community while bolstering social conservatives, who have long argued the experiments are immoral" (Meckler and Adamy, 9/2).

U.S. News & World Report: "Little more than a year after President Obama lifted a ban on federal funding for embryonic stem cell research, the administration is fighting to uphold its decision. The Justice Department is challenging a court ruling handed down last week by U.S. District Judge Royce Lamberth that froze federal funding for embryonic stem cell research. Lamberth's temporary injunction has put dozens of medical experiments on hold—including research on fighting spinal cord injuries, Parkinson's disease, diabetes, and other diseases. The department is seeking a stay of the court's injunction and has filed a notice of plans to take the decision to the U.S. Court of Appeals, should Lamberth stick to his ruling" (Haupt, 9/1).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery